Stay ahead of CINV with the continuous transdermal delivery of SANCUSO11

  • The NCCN recommends prevention as the treatment goal for CINV30
  • If antiemetic failure occurs during the first 24 hours following chemotherapy, a patient is more likely to experience delayed emesis in the same cycle33
  • Apply the SANCUSO® patch a minimum of 24 hours before chemotherapy1
  • SANCUSO® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.1


Control of CINV Within the First 24 Hours of Chemotherapy Is Pivotal33

Control of chemotherapy induced nausea and vomiting (CINV) within the first 24 hours of chemotherapy is pivotal.


Learn how SANCUSO provides continuous CINV prevention